In a note to clients this week, Citi analysts introduced its European "Super 7," telling investors they offer similarly attractive margins to the "Magnificent 7."
The firm notes that while the solid performance of the US Magnificent 7 has captured headlines, "narrowing dynamics have actually been stronger in Europe [year-to-date]."
"Should narrowing continue, we screen for European mega-caps with similar characteristics as the Magnificent 7 that could outperform," wrote the firm. "Our European "Super 7" are cheaper than the US Mag 7, offer similarly attractive margins, and have underperformed the Mag 7 by 70% since the start of '23, leaving room for catch-up."
Citi's European Super 7 is made up of Novo Nordisk (NYSE:NVO), ASML Holdings (ASML), LVMH, SAP (SAP), Schneider, Richemont, and Ferrari (NYSE:RACE). The bank states that while these stocks have performed well of late, they lagged the US Magnificent 7 in 2023.
The bank feels that if the narrowing dynamics were to continue, the Super 7 may follow a similar trajectory as in the US.